ArticleNeurology(R) neuroimmunology & neuroinflammation2019

Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency.

Clemens Küpper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.